Inducible nitric oxide synthase (iNOS) and α-melanocyte-stimulating hormones of iNOS origin play important roles in the allergic reactions of atopic dermatitis in mice

Experimental Dermatology

Volumn 20, Issue 11, 2011, Pages 911-914

  Orita, Kumi ^a   Hiramoto, Keiichi ^a   Kobayashi, Hiromi ^a   Ishii, Masamitsu ^a   Sekiyama, Atsuo ^a   Inoue, Masayasu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

melanocyte stimulating hormone; Atopic dermatitis; Immunoglobulin E; Inducible nitric oxide synthase; Nitric oxide

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; HISTAMINE; IMMUNOGLOBULIN E; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; TRANSFORMING GROWTH FACTOR BETA; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DISEASE EXACERBATION; EAR; HORMONE BLOOD LEVEL; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MAST CELL; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCRATCHING; SKIN ALLERGY; SKIN SENSITIZATION; SWELLING; THICKNESS; TISSUE LEVEL;

ADRENOCORTICOTROPIC HORMONE; ALPHA-MSH; ANIMALS; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HISTAMINE; IMMUNOGLOBULIN E; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE II; OVALBUMIN; PRURITUS; SKIN; TRANSFORMING GROWTH FACTOR BETA; TRYPTASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054094067     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01360.x     Document Type: Article

References (34)

1. Moncada S, Higgs E A. N Engl J Med 1993: 329: 2002-2012.
2. Djupesland P G, Chatkin J M, Qian W et al. Am J Otolaryngol 2001: 22: 19-32.
3. Taniuchi S, Kojima T, Hara K et al. Allergy 2001: 56: 693-695.
4. Yuksel H, Kirmaz C, Yilmaz O et al. Ann Allergy Asthma Immunol 2008: 100: 12-16.
5. Anggard E. Lancet 1994: 343: 1199-1206.
6. Schmidt H H H W, Walter U. Cell 1994: 78: 919-925.
7. Rosenkranz-Weiss P, Sessa W C, Milstien S et al. J Clin Invest 1994: 93: 2236-2243.
8. Cooper K D. J Invest Dermatol 1994: 102: 128-137.
9. Nathan C. FASEB J 1992: 6: 3051-3064.
10. Jin H, He R, Oyoshi M et al. J Invest Dermatol 2009: 129: 31-40.
11. Kagawa Y, Izawa K, Yano H et al. Pharmacology 2010: 85: 286-294.
12. Kim M S, Hur Y G, Kom W G et al. Ann Allergy Asthma Immunol 2011: 106: 54-61.
13. Imai A, Nabe T, Mizutani N et al. Eur J Pharmacol 2001: 423: 63-70.
14. Yaswen L, Diehl N, Brennan M B et al. Nat Med 1999: 5: 1066-1070.
15. Zwermann O, Schulte D M, Reincke M et al. Eur J Endocrinol 2005: 153: 435-444.
16. Kitani A, Fuss I J, Nakamura K et al. J Exp Med 2000: 192: 41-52.
17. Lim S, Ryu J, Shin J A et al. Arterioscler Thromb Vasc Biol 2009: 29: 2138-2145.
18. Iturriza F C, Eberle A N. Neuroendocrinology 1989: 49: 610-616.
19. Zuclich J A. Health Phys 1989: 56: 671-682.
20. Yamamoto M, Haruna T, Yasui K et al. Allergol Int 2007: 56: 139-148.
21. Cookson W. Nat Rev Immunol 2004: 4: 978-988.
22. Strachan D P. Thorax 2000: 55: S2-S10.
23. Rowe A, Farrell A M, Bunker C B. Br J Dermatol 1997: 136: 18-23.
24. Morita H, Semma M, Hori M et al. Int J Dermatol 1995: 34: 294-295.
25. Liew F Y, Li Y, Severn A et al. Eur J Immunol 1991: 21: 2489-2494.
26. Sugita K, Kabashima K, Yoshiki R et al. J Invest Dermatol 2010: 130: 464-471.
27. Hiramoto K, Hashimoto M, Orita K et al. Int Arch Allergy Immunol 2010: 153: 13-18.
28. Hashimoto M, Sato E F, Hiramoto K et al. Allergol Int 2010: 59: 201-206.
29. Hiramoto K, Kobayashi H, Ishi M et al. Exp Dermatol 2010: 19: 132-136.
30. Adachi S, Nakano T, Vliagofits H et al. J Immunol 1999: 163: 3363-3368.
31. Galli S J, Gordon J R, Wershil B K. Curr Opin Immunol 1991: 3: 865-872.
32. Cui H S, Hayasaka S, Zhang X Y et al. Ophthalmic Res 2005: 37: 279-288.
33. Slominski A, Wortsman J, Luger T et al. Physiol Rev 2000: 80: 979-1020.
34. Slominski A. Exp Dermatol 1998: 7: 213-216.